Medtronic said today that it had received approval from the FDA to market its In.Pact Admiral drug-coated balloon (DCB) to treat peripheral artery disease (PAD) in the upper leg. The device is the second DCB to gain FDA approval. Last October the FDA approved CR Bard’s Lutonix DCB for a similar indication. … Click here to read the full post on Forbes. …
FDA Approves New Medtronic Drug-Coated Balloon To Open Blocked Leg Arteries
January 5, 2015 by Leave a Comment
FDA Approves Zilver PTX Drug-Eluting Stent For Peripheral Arterial Disease
November 15, 2012 by 1 Comment
The FDA today approved Cook Medical’s Zilver PTX stent. It is the first drug-eluting stent (DES) approved for the treatment of peripheral arterial disease (PAD) in the superficial femoral and proximal (i.e., above the knee) popliteal artery. The new stent will provide a new treatment option for treating patients with PAD. Current treatments include exercise,…
Recent Comments